Skip to main navigation Skip to search Skip to main content

Eclampsia Incidence, Management and Outcomes Across Multi-Country Surveillance Cohorts: Individual Participant Data Meta-Analysis

  • Silvia Salvi*
  • , Donatella Mandolini
  • , Kitty W.M. Bloemenkamp
  • , Catherine Deneux-Tharaux
  • , Hilde Marie Engjom
  • , Lachmi R. Kodan
  • , Diane Korb
  • , Alexandra Krištúfková
  • , Kari Klungsøyr
  • , Ann Langedock
  • , Camilla Tjønneland Mentzoni
  • , Liam McCullough
  • , Rema Ramakrishnan
  • , T. P. Schaap
  • , Aurélien Seco
  • , Griet Vandenberghe
  • , Kim J.C. Verschueren
  • , Serena Donati
  • ,
  • *Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

1 Downloads (Pure)

Abstract

Objective: To estimate the incidence of eclampsia, characterise maternal and perinatal profiles, and document outcomes across seven countries within the International Obstetric Survey System and identify inter-country differences that may improve maternal and perinatal care. Design: Multi-country analysis of population-based cohort data. Setting: Six high-income countries (Belgium, France, Italy, the Netherlands, Norway, Slovakia) and one upper-middle-income country (Suriname). Population: All women admitted with eclampsia in participating countries between 2012 and 2019. Methods: Individual participant data meta-analysis. Main Outcome Measures: Incidence of eclampsia, maternal demographics, pregnancy characteristics, clinical management, mode of delivery and maternal and perinatal outcomes. Results: 615 cases of eclampsia were notified resulting in a pooled incidence of eclampsia of 2.2 per 10,000 deliveries in high-income countries and 36.6 per 10,000 deliveries in Suriname. About 42% of women were diagnosed with preeclampsia before seizure onset and one-third experienced their first seizure postpartum. Hypertension was the most reported clinical sign (91.1%). Most women were treated with magnesium sulphate (91.1%) and antihypertensive medications (89.8%). Caesarean section was performed in 72.7% of cases. About 53% of births was preterm with most of them linked to antepartum cases. Maternal and neonatal deaths were rare but more frequent in Suriname. Conclusions: The declining incidence of eclampsia in Europe may be attributed to enhanced management, supported by ongoing audits and confidential enquiries; however, potential ascertainment bias limits causal interpretation. Global efforts remain crucial to promote awareness, timely prevention and implement standardised management guidelines for eclampsia across all settings.

Original languageEnglish
Pages (from-to)1631-1642
Number of pages12
JournalBJOG: An International Journal of Obstetrics and Gynaecology
Volume133
Issue number8
Early online date26 Mar 2026
DOIs
Publication statusPublished - Jul 2026

Keywords

  • eclampsia
  • magnesium sulphate
  • maternal health
  • maternal mortality
  • perinatal care

Fingerprint

Dive into the research topics of 'Eclampsia Incidence, Management and Outcomes Across Multi-Country Surveillance Cohorts: Individual Participant Data Meta-Analysis'. Together they form a unique fingerprint.

Cite this